Perspectives on current controversial issues in the management of chronic HBV infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives on current controversial issues in the management of chronic HBV infection
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 57, Issue 11, Pages 828-837
Publisher
Springer Science and Business Media LLC
Online
2022-09-02
DOI
10.1007/s00535-022-01918-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Finite nucleos(t)ide analogue therapy in hepatitis B e antigen‐negative chronic hepatitis B: From an “option” to an “active recommendation”
- (2022) Yun‐Fan Liaw et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Hepatocellular carcinoma incidence is reduced in cirrhotic chronic hepatitis B patients with HBsAg seroclearance comparing to those with viral suppression
- (2022) Rachel Wen-Juei Jeng et al. JOURNAL OF HEPATOLOGY
- Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver
- (2021) William S. Mason et al. Viruses-Basel
- The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analog therapy
- (2021) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
- (2021) Yao-Chun Hsu et al. JOURNAL OF INFECTIOUS DISEASES
- Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis
- (2021) Wen-Juei Jeng et al. SEMINARS IN LIVER DISEASE
- Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population
- (2021) Takashi Kumada et al. HEPATOLOGY RESEARCH
- Highly significant differences in HBsAg kinetics among patients with two types of hepatitis B flare, with and without retreatment
- (2021) Wen-Juei Jeng et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hepatocellular carcinoma after treatment cessation in non‐cirrhotic HBeAg‐negative chronic hepatitis B: A multicentre cohort study
- (2021) Margarita Papatheodoridi et al. LIVER INTERNATIONAL
- Unresolved issues of immune tolerance in chronic hepatitis B
- (2020) Hye Won Lee et al. JOURNAL OF GASTROENTEROLOGY
- Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase
- (2020) Han Ah Lee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Should treatment indications for chronic hepatitis B be expanded?
- (2020) Wen-Juei Jeng et al. Clinical Gastroenterology and Hepatology
- Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis
- (2020) Ryan T. Anderson et al. Clinical Gastroenterology and Hepatology
- Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
- (2020) Wai-Kay Seto et al. GUT
- Hepatitis B flare after cessation of nucleos(t)ide analogue therapy in HBeAg‐negative chronic hepatitis B: To retreat or not to retreat
- (2020) Yun‐Fan Liaw HEPATOLOGY
- medLow Incidence of Adverse Outcomes in Adults with Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
- (2020) Anna S. Lok et al. HEPATOLOGY
- Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding
- (2020) Gregory J Dore et al. Lancet Gastroenterology & Hepatology
- Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
- (2020) Milan J. Sonneveld et al. Clinical Gastroenterology and Hepatology
- Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
- (2020) Hye Won Lee et al. European Journal of Internal Medicine
- Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
- (2019) Mayur Brahmania et al. Clinical Gastroenterology and Hepatology
- High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
- (2019) Gwang Hyeon Choi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
- (2019) Jin-Lin Hou et al. Clinical Gastroenterology and Hepatology
- Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
- (2019) Kin Seng Liem et al. GUT
- Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
- (2019) Yun-Fan Liaw Hepatology International
- Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection
- (2019) Yun-Fan Liaw Nature Reviews Gastroenterology & Hepatology
- Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource‐limited settings
- (2019) Edward John Gane et al. JOURNAL OF VIRAL HEPATITIS
- Role of Biomarkers in Guiding Cure of Viral Hepatitis B
- (2019) Maria Buti et al. SEMINARS IN LIVER DISEASE
- Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone
- (2018) M. Bonacci et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir
- (2018) Jung Woo Shin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
- (2018) Wen-Juei Jeng et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
- (2018) Terry Cheuk-Fung Yip et al. JOURNAL OF HEPATOLOGY
- Immune Tolerance Phase of Chronic Hepatitis B
- (2017) Yun-Fan Liaw et al. GASTROENTEROLOGY
- High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
- (2017) Gi-Ae Kim et al. GUT
- Prognosis of immune-tolerant phase chronic hepatitis B
- (2017) Chia-Ming Chu et al. GUT
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study
- (2017) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance
- (2017) Filippo Oliveri et al. LIVER INTERNATIONAL
- The Concept of Immune Tolerance in Chronic Hepatitis B Virus Infection Is Alive and Well
- (2016) David R. Milich GASTROENTEROLOGY
- HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
- (2016) William S. Mason et al. GASTROENTEROLOGY
- Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
- (2016) Jessica Liu et al. HEPATOLOGY
- Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
- (2016) George Papatheodoridis et al. HEPATOLOGY
- Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis
- (2016) Justin Chien et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
- (2016) Christoph Höner zu Siederdissen et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis
- (2015) Y. C. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
- (2015) M.-L. Chang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Events After Cessation of Lamivudine Therapy in Patients Recovered From Hepatitis B Flare With Hepatic Decompensation
- (2015) Ming-Ling Chang et al. Clinical Gastroenterology and Hepatology
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
- (2014) Ju-Yeon Cho et al. GUT
- Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management
- (2014) Ming-Ling Chang et al. JOURNAL OF HEPATOLOGY
- Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy
- (2013) Yun-Fan Liaw JOURNAL OF HEPATOLOGY
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- (2012) Stephanos J. Hadziyannis et al. GASTROENTEROLOGY
- Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B
- (2012) Patrick T.F. Kennedy et al. GASTROENTEROLOGY
- Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
- (2012) Tai-Chung Tseng et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Historical Overview of Immunological Tolerance
- (2012) R. H. Schwartz Cold Spring Harbor Perspectives in Biology
- Predictive Effect of Serial Serum Alanine Aminotransferase Levels on Spontaneous HBeAg Seroconversion in Chronic Genotype B and C HBV–Infected Children
- (2011) Jia-Feng Wu et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death
- (2010) Jin–De Chen et al. GASTROENTEROLOGY
- Variability in the upper limit of normal for serum alanine aminotransferase levels: A statewide study
- (2009) Anand Dutta et al. HEPATOLOGY
- Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
- (2009) Dar-In Tai et al. HEPATOLOGY
- Hepatitis B virus infection
- (2009) Yun-Fan Liaw et al. LANCET
- Influence of Local Reference Populations on Upper Limits of Normal for Serum Alanine Aminotransferase Levels
- (2008) Brent A. Neuschwander-Tetri ARCHIVES OF INTERNAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search